Studio LSD (STUDIOLSD)₹8.700.00%Media & Entertainment
In the Mar 2026 quarter (standalone), Studio LSD reported sales of ₹32.83 Cr, down 21.8% from Mar 2025, and net profit of ₹2.48 Cr, down 47.6% year on year. For the year to Mar 2026, sales were ₹72.09 Cr and net profit −₹0.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 62.54 | 41.96 | 39.28 | 32.83 |
| Expenses | 53.26 | 35.96 | 44.22 | 30.63 |
| Operating Profit | 9.41 | 6.04 | −4.80 | 2.29 |
| OPM % | 15.1% | 14.5% | −12.2% | 7.0% |
| Other Income | 0.20 | 0.31 | 1.04 | 1.16 |
| Interest | 0.00 | 0.00 | 0.01 | 0.00 |
| Depreciation | 0.11 | 0.16 | 0.09 | 0.34 |
| Profit before tax | 9.55 | 6.24 | −3.90 | 3.13 |
| Tax % | 26.3% | 24.1% | −10.3% | 20.2% |
| Net Profit | 7.01 | 4.73 | −3.48 | 2.48 |
| EPS (Rs) | 14.65 | 1.17 | −0.68 | 0.49 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 46.84 | 5.41 | 14.62 | 46.69 | 102 | 104 | 72.09 |
| Expenses | 44.85 | 6.96 | 13.66 | 43.06 | 87.90 | 89.12 | 74.83 |
| Operating Profit | 2.14 | −1.51 | 0.97 | 3.73 | 14.79 | 15.48 | −2.50 |
| OPM % | 4.6% | −28.0% | 6.7% | 8.1% | 14.5% | 14.9% | −3.5% |
| Other Income | 0.00 | 0.38 | 0.00 | 0.03 | 0.01 | 0.49 | 2.21 |
| Interest | 0.63 | 0.06 | 0.03 | 0.09 | 0.00 | 0.00 | 0.02 |
| Depreciation | 0.05 | 0.04 | 0.02 | 0.03 | 0.19 | 0.28 | 0.44 |
| Profit before tax | 1.47 | −1.26 | 0.92 | 3.65 | 14.69 | 15.79 | −0.78 |
| Tax % | 26.1% | −0.8% | −1.1% | 23.1% | 25.7% | 26.0% | 29.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.08 | −1.23 | 0.90 | 2.78 | 10.88 | 11.65 | −0.99 |
| EPS (Rs) | 1,093.78 | −1,243.40 | 912.69 | 2,800.21 | 10,936.91 | 2.86 | −0.20 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.18 | 0.00 |
| Reserves | 2.50 | 1.26 | 2.17 | 4.96 | 15.91 | 19.42 | 79.44 |
| Borrowings | 1.22 | 0.92 | 0.45 | 0.07 | 0.00 | 0.00 | 0.14 |
| Other Liabilities | 15.00 | 3.15 | 1.54 | 13.20 | 20.72 | 19.22 | 13.85 |
| Total Liabilities | 18.72 | 5.33 | 4.16 | 18.23 | 36.63 | 46.82 | 93.43 |
| Fixed Assets | 0.08 | 0.08 | 0.07 | 0.25 | 0.76 | 0.52 | 6.46 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.02 | 0.02 | 1.71 | 11.03 | 7.40 |
| Other Assets | 18.64 | 5.25 | 4.07 | 17.96 | 34.16 | 35.27 | 79.57 |
| Inventories | 0.00 | 0.00 | 0.84 | 0.67 | 0.46 | 9.41 | 17.07 |
| Trade receivables | 11.52 | 4.14 | 0.50 | 14.87 | 23.90 | 19.98 | 21.15 |
| Cash & equivalents | 2.19 | 0.25 | 0.27 | 0.59 | 5.75 | 2.34 | 31.29 |
| Total Assets | 18.72 | 5.33 | 4.16 | 18.23 | 36.63 | 46.82 | 93.43 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 2.50 | −2.06 | 0.56 | 1.01 | 7.59 | 5.78 | −22.29 |
| Cash from investing activity | −0.09 | −0.05 | −0.02 | −0.19 | −2.37 | −9.15 | −1.53 |
| Cash from financing activity | −0.33 | 0.14 | −0.49 | −0.47 | −0.06 | 0.00 | 52.45 |
| Net cash flow | 2.06 | −1.95 | 0.03 | 0.33 | 5.16 | −3.41 | 28.96 |
| Capex | 0.11 | 0.05 | 0.03 | 0.23 | 0.69 | 0.05 | 6.43 |
| Free cash flow | 2.38 | −2.08 | 0.52 | 0.77 | 6.87 | 5.68 | −28.59 |
| CFO / OP % | 155.9% | 136.0% | 55.0% | 49.0% | 77.0% | 62.9% | 817.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 89 | 278 | 12 | 116 | 84 | 69 | 106 |
| Inventory days | — | — | — | — | — | — | 118 |
| Days payable | — | — | — | — | — | — | 63 |
| Cash conversion cycle | 89 | 278 | 12 | 116 | 84 | 69 | 163 |
| Working capital days | −10 | 30 | 6 | 22 | 16 | 39 | 178 |
| ROCE % | — | −40.1% | 39.8% | 98.1% | 140.5% | 72.8% | −1.4% |
For the Mar 2026 quarter, Studio LSD reported sales of ₹32.83 Cr, down 21.8% year on year and net profit of ₹2.48 Cr, down 47.6% year on year. The operating margin was 7.0%.
Studio LSD's sales for the year to Mar 2026 were ₹72.09 Cr.
Net profit for the year to Mar 2026 was −₹0.99 Cr. Earnings per share over the same trailing period were ₹−0.20.
Studio LSD reported borrowings of ₹0.14 Cr at Mar 2026, against cash and equivalents of ₹31.29 Cr.
Cash from operations was −₹22.29 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹28.59 Cr.